Eversept Partners, LP Alector, Inc. Transaction History
Eversept Partners, LP
- $904 Million
- Q1 2025
A detailed history of Eversept Partners, LP transactions in Alector, Inc. stock. As of the latest transaction made, Eversept Partners, LP holds 617,418 shares of ALEC stock, worth $870,559. This represents 0.08% of its overall portfolio holdings.
Number of Shares
617,418
Previous 200,095
208.56%
Holding current value
$870,559
Previous $378,000
100.79%
% of portfolio
0.08%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding ALEC
# of Institutions
147Shares Held
55.5MCall Options Held
56.4KPut Options Held
23.2K-
Ra Capital Management, L.P. Boston, MA9.7MShares$13.7 Million0.25% of portfolio
-
Black Rock Inc. New York, NY9.1MShares$12.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.05MShares$8.53 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.96MShares$2.77 Million0.0% of portfolio
-
State Street Corp Boston, MA1.64MShares$2.31 Million0.0% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $116M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...